Goldman Sachs Initiates Coverage of Pacific Biosciences of California (PACB) with Buy Recommendation
Fintel reports that on June 30, 2023, Goldman Sachs initiated coverage of Pacific Biosciences of California (NASDAQ:PACB) with a Buy recommendation.